NO154056C - Analogifremgangsmaate for fremstilling av terapeutisk aktive isopropylamino-pyrimidin-hydroksy-derivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive isopropylamino-pyrimidin-hydroksy-derivater.

Info

Publication number
NO154056C
NO154056C NO801235A NO801235A NO154056C NO 154056 C NO154056 C NO 154056C NO 801235 A NO801235 A NO 801235A NO 801235 A NO801235 A NO 801235A NO 154056 C NO154056 C NO 154056C
Authority
NO
Norway
Prior art keywords
isopropylamino
preparation
therapeutic active
hydroxy derivatives
analogy procedure
Prior art date
Application number
NO801235A
Other languages
English (en)
Other versions
NO154056B (no
NO801235L (no
Inventor
Andre Esanu
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of NO801235L publication Critical patent/NO801235L/no
Publication of NO154056B publication Critical patent/NO154056B/no
Publication of NO154056C publication Critical patent/NO154056C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
NO801235A 1979-04-30 1980-04-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive isopropylamino-pyrimidin-hydroksy-derivater. NO154056C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7914987 1979-04-30

Publications (3)

Publication Number Publication Date
NO801235L NO801235L (no) 1980-10-31
NO154056B NO154056B (no) 1986-04-01
NO154056C true NO154056C (no) 1986-07-09

Family

ID=10504858

Family Applications (2)

Application Number Title Priority Date Filing Date
NO801234A NO154055C (no) 1979-04-30 1980-04-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive isopropylamino-pyrimidin-hydroksy-derivater.
NO801235A NO154056C (no) 1979-04-30 1980-04-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive isopropylamino-pyrimidin-hydroksy-derivater.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO801234A NO154055C (no) 1979-04-30 1980-04-28 Analogifremgangsmaate for fremstilling av terapeutisk aktive isopropylamino-pyrimidin-hydroksy-derivater.

Country Status (26)

Country Link
JP (2) JPS55145670A (no)
AR (2) AR222869A1 (no)
AT (2) AT380013B (no)
BE (2) BE882594A (no)
CH (2) CH645633A5 (no)
DK (2) DK183880A (no)
EG (2) EG14259A (no)
ES (2) ES8103061A1 (no)
FI (2) FI66358C (no)
FR (2) FR2455588A1 (no)
GB (2) GB2055801B (no)
HK (2) HK55583A (no)
IE (2) IE49591B1 (no)
IN (2) IN154067B (no)
IT (2) IT1141487B (no)
LU (2) LU82333A1 (no)
MA (1) MA18824A1 (no)
MX (2) MX6514E (no)
MY (2) MY8400204A (no)
NL (2) NL8002271A (no)
NO (2) NO154055C (no)
NZ (2) NZ193422A (no)
OA (2) OA06527A (no)
PT (2) PT71155A (no)
SG (2) SG22583G (no)
ZA (2) ZA801960B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63145595U (no) * 1987-03-13 1988-09-26
JPS645795U (no) * 1987-06-26 1989-01-13
JPH01100695U (no) * 1987-12-21 1989-07-06
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines

Also Published As

Publication number Publication date
FR2455589B1 (no) 1981-07-10
FR2455588A1 (fr) 1980-11-28
NZ193422A (en) 1981-12-15
IE800864L (en) 1980-10-30
PT71155A (en) 1980-05-01
AR222870A1 (es) 1981-06-30
IT8021543A0 (it) 1980-04-22
SG22583G (en) 1983-12-16
LU82332A1 (fr) 1980-07-02
NO154055B (no) 1986-04-01
GB2055801A (en) 1981-03-11
GB2054556B (en) 1983-01-26
ES491000A0 (es) 1981-02-16
EG14284A (en) 1983-09-30
IN154067B (no) 1984-09-15
ES490999A0 (es) 1981-02-16
ES8103060A1 (es) 1981-02-16
FI66358B (fi) 1984-06-29
JPS6116272B2 (no) 1986-04-28
NO154056B (no) 1986-04-01
JPS55145670A (en) 1980-11-13
ZA801960B (en) 1981-04-29
BE882593A (fr) 1980-07-31
NZ193421A (en) 1981-11-19
FI801083A (fi) 1980-10-31
IT1141487B (it) 1986-10-01
LU82333A1 (fr) 1980-07-02
AR222869A1 (es) 1981-06-30
OA06525A (fr) 1981-07-31
NO801235L (no) 1980-10-31
FR2455588B1 (no) 1983-04-15
MA18824A1 (fr) 1980-12-31
CH645633A5 (en) 1984-10-15
GB2055801B (en) 1983-02-09
NO801234L (no) 1980-10-31
MX5878E (es) 1984-08-16
OA06527A (fr) 1981-07-31
IN154066B (no) 1984-09-15
SG22283G (en) 1983-12-16
DK183880A (da) 1980-10-31
ATA221580A (de) 1985-08-15
IE49709B1 (en) 1985-11-27
CH645361A5 (en) 1984-09-28
AT380012B (de) 1986-03-25
FI801084A (fi) 1980-10-31
IE49591B1 (en) 1985-10-30
PT71154A (en) 1980-05-01
FR2455589A1 (fr) 1980-11-28
JPS55145671A (en) 1980-11-13
BE882594A (fr) 1980-07-31
NO154055C (no) 1986-07-09
NL8002272A (nl) 1980-11-03
EG14259A (en) 1983-09-30
IE800865L (en) 1980-10-30
ZA801958B (en) 1981-04-29
GB2054556A (en) 1981-02-18
DK183780A (da) 1980-10-31
FI66358C (fi) 1984-10-10
NL8002271A (nl) 1980-11-03
ATA221680A (de) 1985-08-15
FI66359B (fi) 1984-06-29
HK55683A (en) 1983-11-25
JPS6116273B2 (no) 1986-04-28
IT1141296B (it) 1986-10-01
MX6514E (es) 1985-06-26
AT380013B (de) 1986-03-25
ES8103061A1 (es) 1981-02-16
IT8021542A0 (it) 1980-04-22
FI66359C (fi) 1984-10-10
MY8400204A (en) 1984-12-31
HK55583A (en) 1983-11-25
MY8400203A (en) 1984-12-31

Similar Documents

Publication Publication Date Title
NO152899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glycerolderivater.
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO149102C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater
NO156864C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO157817C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glycinamidderivater.
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO161117C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO153496C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive indolizin-derivater.
NO159654C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater.
NO154013C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sesquiterpenderivater.
NO154054C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksypyrimidinderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO151660C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO154052C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.
NO155539C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme isokinolinderivater.
NO794318L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO154088C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner.
NO154056C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isopropylamino-pyrimidin-hydroksy-derivater.
NO152839C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.